Sputnik V vaccine News

Sputnik V, a two-shot vaccine, showed 97.6% efficacy based on the analysis of data from 3.8 million vaccinated people in Russia. In July, RDIF had said that the Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September. Sputnik V vaccine has been registered in 67 countries so far.

Delhi’s Indraprastha Apollo hospital and Fortis Healthcare begins administering the Sputnik V vaccine. "On-the-spot registration and walk-in facility for Sputnik V is currently restricted, we are encouraging beneficiaries to take appointments through the CoWin app," the official said.

Delhi’s Indraprastha Apollo hospital begins administering the Sputnik V vaccine Beneficiaries can now register through CoWin app

Sputnik V is also likely to be available to people at Indraprastha Apollo Hospital in Delhi by the end of this week.

The research group tested the vaccine on children aged between eight and 12 and found no side effects among the test group.

Hyderabad-based Dr Reddy’s Laboratories has partnered with the Russian Direct Investment Fund (RDIF) for the rollout of the two-dose vaccine in India. DCGI granted permission to the Pune-based SII to manufacture Sputnik V in India. The Centre has fixed the price of the Sputnik V vaccine at private hospitals at Rs 1,410 per dose.

Amid allegations of profiteering by the opposition, the Center has fixed the maximum price that private hospitals can charge for COVID vaccines. Covishield has been priced at ₹780 per dose, Russian vaccine Sputnik-V at ₹1,145 per dose and indigenously manufactured Covaxin at ₹1,410 per dose.

The largest consignment of 3 million doses of Sputnik V vaccine landed in Hyderabad This shipment completed all processes and was dispatched in less than 90 minutes, GHAC said. The Sputnik V vaccine requires specialised handling and storage, requiring to be kept at a temperature of -20o C

Dr Reddy's Laboratories, the Indian partner of the Russian Direct Investment Fund (RDIF), said it has initiated the rollout of 'Sputnik V' in India with the first dose in Hyderabad on Friday.

Sputnik V vaccine to be available in 10 days. First batch/consignment of Sputnik V reached on 1 May. 3 lakh doses of the Russian vaccines will be available in the market soon.

First batch of SputnikV vaccine arrives in Hyderabad Sputnik V is the third COVID-19 vaccine to have received approval in India It has been handed over to Dr Reddy's Laboratories and will be sent for regulatory approval

The Central Drugs Standard Control Organization (CDSCO) on Monday (April 12) approved Dr Reddy's application for the emergency use of Russia's Sputnik-V vaccine. It is worth noting that Sputnik-V is the third COVID-19 vaccine to be officially approved after Covishield and Covaxin.

Developers of the Russian coronavirus vaccine Sputnik V signed an agreement with British AstraZeneca. AstraZeneca developed its vaccine with Oxford University. Russian President Vladimir Putin hailed cooperation between AstraZeneca and Russian scientists

Russia's permanent mission, the Health Ministry will present the Sputnik V vaccine at the UN today In August, Russia`s Health Ministry registered the world`s first vaccine for the prevention of COVID-19. It is being developed by the Gamaleya Research Centre.

First batch of Sputnik V vaccine to reach Kanpur by next week. Phase 2 and 3 human clinical trials will be conducted of the vaccine. As many as 180 volunteers have registered for the trials.